Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001)
Chapter: Appendix A: Januaray 11, 2001 - Meeting Agenda
Page 71
APPENDIX A
January 11, 2001
Meeting Agenda
IMMUNIZATION SAFETY REVIEW COMMITTEE ORGANIZATIONAL MEETING
National Academies Building
2101 Constitution Avenue, NW
Washington, DC
|
9:00–9:15 a.m. |
Welcome and Introductions Marie McCormick, M.D., Sc.D., Chair, Immunization Safety Review Committee |
|
9:15–9:45 a.m. |
Presentation of the Charge to the Committee Martin G. Myers, M.D., Director, National Vaccine Program Office, Department of Health and Human Services Walter A. Orenstein, M.D., Director, National Immunization Program, Centers for Disease Control and Prevention Carole A. Heilman, Ph.D., Director, Division of Microbiology and Infectious Diseases, National Institute for Allergies and Infectious Diseases, National Institutes of Health |
|
9:45–10:45 a.m. |
Perspectives on Vaccine Safety The Honorable Henry Waxman, Ranking minority member, Committee on Government Reform, United States House of Representatives The Honorable Dave Weldon, United States House of Representatives |
Page 72
S. Elizabeth Clay, Professional Staff Member, Committee on Government Reform, United States House of Representatives
|
11:00–11:30 a.m.
|
Perspectives on Vaccine Safety Louis Cooper, M.D., Professor of Pediatrics, Columbia University, and Vice-President, American Academy of Pediatrics
|
11:30 a.m.–12:00 p.m.
|
Perspectives on Vaccine Safety Barbara Loe Fisher, President and Co-Founder, National Vaccine Information Center
|
12:00–12:30 p.m.
|
Current Vaccine Safety Data Sources Robert T. Chen, M.D., M.A., Chief, Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention
|
1:30–2:00 p.m.
|
Causality Assessments in IOM Vaccine Safety Studies Richard B. Johnston, Jr., M.D., Professor of Pediatrics, University of Colorado
|
2:00–2:30 p.m.
|
Methodological Considerations in Evaluating Evidence David Tollerud, M.D., M.P.H., Professor, Public Health, Medicine, and Community and Preventive Medicine (EOH), Director, Center for Environmental and Occupational Health, School of Public Health, MCP Hahnemann University
|
2:30–3:00 p.m.
|
Decision-Making Under Uncertainty: The Case of Iodine-131 Robert S. Lawrence, M.D., Edyth Schoenrich Professor of Preventive Medicine and Professor of Health Policy, Johns Hopkins University School of Hygiene and Public Health
|
3:15–3:45 p.m.
|
Risk Assessment and Management Under Uncertainty: Lessons From Swine Flu and HIV in Blood Products Michael Stoto, Ph.D., Professor and Chair, Epidemiology & Biostatistics, George Washington University |
Page 73
|
3:45–4:15 p.m. |
Decision Analysis: Applications to Immunization Policy Richard Rheingans, Ph.D., Research Assistant Professor, Rollins School of Public Health, Emory University |
|
4:15–4:45 p.m. |
Risk Perception and Risk Communication Overview Baruch Fischhoff, Ph.D., Professor of Social and Decision Sciences and of Engineering and Public Policy, Carnegie Mellon University |
|
4:45–5:00 p.m. |
Research in Public Perceptions of Vaccine Safety Beth Hibbs, R.N., M.P.H., Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention |
|
5:00–5:30 p.m. |
Framework for Considering Issues and Recommendations Amy Fine, M.P.H., B.S.N., Health Policy/Program Consultant, Washington, DC |
|
5:30–6:00 p.m. |
Open Discussion |
